Apaf-1 and caspase-9 are required for cytokine withdrawal-induced apoptosis of mast cells but dispensable for their functional and clonogenic death
Details
Publication Year 2006-03-01,Volume 107,Issue #5,Page 1872-1877
Journal Title
BLOOD
Publication Type
Journal Article
Abstract
Cytokines promote survival of mast cells by inhibiting apoptotic pathways regulated by the Bcl-2 protein family. We previously showed that lymphocyte apoptosis can proceed via a Bcl-2-inhibitable pathway independent of the canonical initiator caspase, caspase-9, and its adaptor, Apaf-1. Here we report that mast cells lacking caspase-9 or Apaf-1 are refractory to apoptosis after cytotoxic insults but still lose effector function and ability to proliferate. In response to cytokine deprivation or DNA damage, fetal liver-derived mast cells lacking Apaf-1 or caspase-9 failed to undergo apoptosis. Nevertheless, the cytokine-starved cells were not functionally alive, because, unlike those overexpressing Bcl-2, they could not degranulate on Fc epsilon receptor stimulation or resume proliferation on re-addition of cytokine. Furthermore, mast cells lacking Apaf-1 or caspase-9 had no survival advantage over wild-type counterparts in vivo. These results indicate that the Apaf-1/caspase-9-independent apoptotic pathway observed in lymphocytes is ineffective in cytokine-deprived mast cells. However, although Apaf-1 and caspase-9 are essential for mast cell apoptosis, neither is required for the functional or clonogenic death of the cells, which may be due to mitochondrial dysfunction.
Publisher
AMER SOC HEMATOLOGY
Keywords
BCL-X-L; KIT-LIGAND; PROLIFERATION; ACTIVATION; EXPRESSION; CLEAVAGE; SURVIVAL; FAMILY; BIM
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2006-03-01 12:00:00
An error has occurred. This application may no longer respond until reloaded. Reload 🗙